Cellebrite (CLBT) furnishes Q3 2025 results press release in Form 6-K

Rhea-AI Filing Summary

Cellebrite DI Ltd. submitted a Form 6-K to furnish a press release titled “Cellebrite Announces Third-Quarter 2025 Results.” The filing states that the press release, dated November 12, 2025, contains the company’s third-quarter 2025 results and GAAP financial statement tables.

The filing also explains that these GAAP financial statement tables are incorporated by reference into Cellebrite’s existing registration statements on Form S-8 and Form F-3 with the U.S. Securities and Exchange Commission. The report is signed on behalf of the company by its Chief Financial Officer, David Barter.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of November, 2025

Commission File Number 001-40772

Cellebrite DI Ltd.

(Translation of registrant’s name into English)

94 Shlomo Shmelzer Road

Petah Tikva 4970602, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

EXPLANATORY NOTE

On November 12, 2025, Cellebrite DI Ltd. (the “Registrant” or “Cellebrite”) issued a press release titled “Cellebrite Announces Third-Quarter 2025 Results.” A copy of this press release is furnished as Exhibit 99.1 herewith.

The GAAP financial statements tables contained in the press release attached to this report on Form 6-K are incorporated by reference into the Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022.

1

EXHIBIT INDEX

Exhibit		Description
99.1		Press release titled “Cellebrite Announces Third-Quarter 2025 Results” (furnished herewith).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cellebrite DI Ltd.
Date: November 12, 2025	By:	/s/ David Barter
		David Barter
		Chief Financial Officer

3

FAQ

What does Cellebrite (CLBT) disclose in this Form 6-K?

The Form 6-K states that Cellebrite DI Ltd. furnished a press release titled “Cellebrite Announces Third-Quarter 2025 Results,” which contains its third-quarter 2025 results and GAAP financial statement tables.

Which financial statements are incorporated by reference in Cellebrite’s (CLBT) 6-K?

The filing explains that the GAAP financial statements tables included in the attached press release are incorporated by reference into Cellebrite’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) and Form F-3 (File No. 333-259826).

Which exhibit is attached to this Cellebrite (CLBT) Form 6-K?

The exhibit index lists Exhibit 99.1 as the press release titled “Cellebrite Announces Third-Quarter 2025 Results,” which is furnished with the report.

Who signed this Cellebrite (CLBT) Form 6-K?

The report was signed on behalf of Cellebrite DI Ltd. by David Barter, who is identified as the company’s Chief Financial Officer.

What is the time period covered by the Cellebrite (CLBT) 6-K filing?

The Form 6-K is identified as a report for the month of November 2025, and the explanatory note refers to a press release issued on November 12, 2025.

Which SEC annual report form does Cellebrite (CLBT) use?

The cover page indicates that Cellebrite files its annual reports under Form 20-F, consistent with its status as a foreign private issuer.